Skip to main content
Erschienen in: Infection 6/2022

04.05.2022 | Original Paper

Tularemia research activity: a bibliometric analysis between 1980 and 2020

verfasst von: Erhan Kaya, Hüseyin Üçer

Erschienen in: Infection | Ausgabe 6/2022

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Tularemia disease attracts attention as an important contagious zoonosis that has increased its impact in recent years. The aim of the study is to analyze the publications on tularemia between 1980 and 2020.

Methods

We performed literature retrieval in the Web of Science (WoS) on 22 September 2021. Search terms were “Francisella tularensis” and “Tularemia” in the article title for the period between January 1980 and December 2020. We determined the number of articles, keywords, countries, authors, and institutions for each publication. We visualized the data with the VOS viewer tool.

Results

After all inclusion and exclusion criteria were applied finally, 1688 articles were analyzed. The number of articles has increased in recent years. The three most productive countries in tularemia were the USA (777 articles 46.03%), Sweden (113 articles 6.69%), and Turkey (95 articles, 5.63%). Most of the articles were from the journal of Infection and Immunity (II), Plos one, Journal of Clinical Microbiology (JCM), Emerging Infectious Diseases (EID), and Vaccine. Sjostedt A. and Umea University—Sweden were the most influential author and institution.

Conclusions

Productivity trend has been shown to increase in tularemia. High-income countries had a great influence on the literature in the field. Publications from the USA were in a high percentage among all articles. Related work may lead to the future direction of this dossier in the next years.
Literatur
1.
Zurück zum Zitat Sjöstedt A. Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations. Ann N Y Acad Sci. 2007;1105:1–29.CrossRefPubMed Sjöstedt A. Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations. Ann N Y Acad Sci. 2007;1105:1–29.CrossRefPubMed
2.
Zurück zum Zitat Maurin M, Gyuranecz M. Tularaemia: clinical aspects in Europe. Lancet Infect Dis. 2016;16:113–24.CrossRefPubMed Maurin M, Gyuranecz M. Tularaemia: clinical aspects in Europe. Lancet Infect Dis. 2016;16:113–24.CrossRefPubMed
3.
Zurück zum Zitat Maurin M. Francisella tularensis as a potential agent of bioterrorism? Expert Rev Anti Infect Ther. 2015;13:141–4.CrossRefPubMed Maurin M. Francisella tularensis as a potential agent of bioterrorism? Expert Rev Anti Infect Ther. 2015;13:141–4.CrossRefPubMed
4.
Zurück zum Zitat Oyston PC, Sjöstedt A, Titball RW. Tularaemia: bioterrorism defence renews interest in Francisella tularensis. Nat Rev Microbiol. 2004;2:967–78.CrossRefPubMed Oyston PC, Sjöstedt A, Titball RW. Tularaemia: bioterrorism defence renews interest in Francisella tularensis. Nat Rev Microbiol. 2004;2:967–78.CrossRefPubMed
6.
Zurück zum Zitat Lester Rothfeldt LK, Jacobs RF, Wheeler JG, Weinstein S, Haselow DT. Variation in tularemia clinical manifestations—Arkansas, 2009–2013. In Open forum infectious diseases. 2017;4:1.CrossRef Lester Rothfeldt LK, Jacobs RF, Wheeler JG, Weinstein S, Haselow DT. Variation in tularemia clinical manifestations—Arkansas, 2009–2013. In Open forum infectious diseases. 2017;4:1.CrossRef
7.
Zurück zum Zitat Akhvlediani N, Burjanadze I, Baliashvili D, Tushishvili T, Broladze M, Navdarashvili A, et al. Tularemia transmission to humans: a multifaceted surveillance approach. Epidemiol Infect. 2018;146:2139–45.CrossRefPubMedPubMedCentral Akhvlediani N, Burjanadze I, Baliashvili D, Tushishvili T, Broladze M, Navdarashvili A, et al. Tularemia transmission to humans: a multifaceted surveillance approach. Epidemiol Infect. 2018;146:2139–45.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Mailles A, Vaillant V. 10 years of surveillance of human tularaemia in France. Eurosurveillance. 2014;19:20956.CrossRefPubMed Mailles A, Vaillant V. 10 years of surveillance of human tularaemia in France. Eurosurveillance. 2014;19:20956.CrossRefPubMed
9.
Zurück zum Zitat Trevisanato SI. Did an epidemic of tularemia in ancient Egypt affect the course of world history? Med Hypotheses. 2004;63:905–10.CrossRefPubMed Trevisanato SI. Did an epidemic of tularemia in ancient Egypt affect the course of world history? Med Hypotheses. 2004;63:905–10.CrossRefPubMed
10.
Zurück zum Zitat Eliasson H, Broman T, Forsman M, Bäck E. Tularemia: current epidemiology and disease management. Infect Dis Clin. 2006;20:289–311.CrossRef Eliasson H, Broman T, Forsman M, Bäck E. Tularemia: current epidemiology and disease management. Infect Dis Clin. 2006;20:289–311.CrossRef
11.
Zurück zum Zitat McEntire CR, Song KW, McInnis RP, Rhee JY, Young M, Williams E, et al. Neurologic manifestations of the world health organization’s list of pandemic and epidemic diseases. Front Neurol. 2021;12:161.CrossRef McEntire CR, Song KW, McInnis RP, Rhee JY, Young M, Williams E, et al. Neurologic manifestations of the world health organization’s list of pandemic and epidemic diseases. Front Neurol. 2021;12:161.CrossRef
12.
Zurück zum Zitat Dryselius R, Hjertqvist M, Mäkitalo S, Lindblom A, Lilja T, Eklöf D, et al. Large outbreak of tularaemia, central Sweden, July to September 2019. Eurosurveillance. 2019;24:1900603.CrossRefPubMedPubMedCentral Dryselius R, Hjertqvist M, Mäkitalo S, Lindblom A, Lilja T, Eklöf D, et al. Large outbreak of tularaemia, central Sweden, July to September 2019. Eurosurveillance. 2019;24:1900603.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Oyston PC, Quarry JE. Tularemia vaccine: past, present and future. Antonie Van Leeuwenhoek. 2005;87:277–81.CrossRefPubMed Oyston PC, Quarry JE. Tularemia vaccine: past, present and future. Antonie Van Leeuwenhoek. 2005;87:277–81.CrossRefPubMed
14.
Zurück zum Zitat Ogden NH, Artsob H, Margos G, Tsao J, Sonenshine DE, Roe M. Non-rickettsial tick-borne bacteria and the diseases they cause. Biology of ticks. 2011;2:278–312. Ogden NH, Artsob H, Margos G, Tsao J, Sonenshine DE, Roe M. Non-rickettsial tick-borne bacteria and the diseases they cause. Biology of ticks. 2011;2:278–312.
15.
Zurück zum Zitat Bouchard L, Albertini M, Batista R, De Montigny J. Research on health inequalities: a bibliometric analysis (1966–2014). Soc Sci Med. 2015;141:100–8.CrossRefPubMed Bouchard L, Albertini M, Batista R, De Montigny J. Research on health inequalities: a bibliometric analysis (1966–2014). Soc Sci Med. 2015;141:100–8.CrossRefPubMed
16.
17.
Zurück zum Zitat Smith DR, Gehanno JF, Takahashi K. Bibliometric research in occupational health. Ind Health. 2008;46:519–22.CrossRefPubMed Smith DR, Gehanno JF, Takahashi K. Bibliometric research in occupational health. Ind Health. 2008;46:519–22.CrossRefPubMed
18.
Zurück zum Zitat Zheng S, He A, Yu Y, Jiang L, Liang J, Wang P. Research trends and hotspots of health-related quality of life: a bibliometric analysis from 2000 to 2019. Health Qual Life Outcomes. 2021;19:1–13.CrossRef Zheng S, He A, Yu Y, Jiang L, Liang J, Wang P. Research trends and hotspots of health-related quality of life: a bibliometric analysis from 2000 to 2019. Health Qual Life Outcomes. 2021;19:1–13.CrossRef
19.
Zurück zum Zitat Li T, Ho YS, Li CY. Bibliometric analysis on global Parkinson’s disease research trends during 1991–2006. Neurosci Lett. 2008;441:248–52.CrossRefPubMed Li T, Ho YS, Li CY. Bibliometric analysis on global Parkinson’s disease research trends during 1991–2006. Neurosci Lett. 2008;441:248–52.CrossRefPubMed
20.
Zurück zum Zitat Liao J, Wang J, Liu Y, Li J, He Q, Jiang W, Dong Y. The most cited articles in coronary heart disease: a bibliometric analysis between 1970 and 2015. Int J Cardiol. 2016;222:1049–52.CrossRefPubMed Liao J, Wang J, Liu Y, Li J, He Q, Jiang W, Dong Y. The most cited articles in coronary heart disease: a bibliometric analysis between 1970 and 2015. Int J Cardiol. 2016;222:1049–52.CrossRefPubMed
21.
Zurück zum Zitat Yang KL, Jin XY, Gao Y, Xie J, Liu M, Zhang JH, et al. Bibliometric analysis of researches on traditional Chinese medicine for coronavirus disease 2019 (COVID-19). Integrative medicine research. 2020;9: 100490.CrossRefPubMedPubMedCentral Yang KL, Jin XY, Gao Y, Xie J, Liu M, Zhang JH, et al. Bibliometric analysis of researches on traditional Chinese medicine for coronavirus disease 2019 (COVID-19). Integrative medicine research. 2020;9: 100490.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Kocyigit BF, Akyol A. Bibliometric analysis of publication activity in the field of familial Mediterranean fever in 2010–2019: a Scopus-based study. Rheumatol Int. 2021;41:2015–23.CrossRefPubMed Kocyigit BF, Akyol A. Bibliometric analysis of publication activity in the field of familial Mediterranean fever in 2010–2019: a Scopus-based study. Rheumatol Int. 2021;41:2015–23.CrossRefPubMed
23.
Zurück zum Zitat Akyol A, Kocyigit BF. Ankylosing spondylitis rehabilitation publications and the global productivity: a web of science-based bibliometric analysis (2000–2019). Rheumatol Int. 2021;41:2007–14.CrossRefPubMed Akyol A, Kocyigit BF. Ankylosing spondylitis rehabilitation publications and the global productivity: a web of science-based bibliometric analysis (2000–2019). Rheumatol Int. 2021;41:2007–14.CrossRefPubMed
25.
Zurück zum Zitat Kiraz M, Demir E. A bibliometric analysis of publications on spinal cord injury during 1980–2018. World neurosurgery. 2020;136:e504–13.CrossRefPubMed Kiraz M, Demir E. A bibliometric analysis of publications on spinal cord injury during 1980–2018. World neurosurgery. 2020;136:e504–13.CrossRefPubMed
26.
Zurück zum Zitat Sweileh WM. Global research trends of world health organization’s top eight emerging pathogens. Glob Health. 2017;13:1–19.CrossRef Sweileh WM. Global research trends of world health organization’s top eight emerging pathogens. Glob Health. 2017;13:1–19.CrossRef
27.
Zurück zum Zitat Demir E, Comba A. The evolution of celiac disease publications: a holistic approach with bibliometric analysis 2020. Irish J Med Sci. 1971;189:267–76.CrossRef Demir E, Comba A. The evolution of celiac disease publications: a holistic approach with bibliometric analysis 2020. Irish J Med Sci. 1971;189:267–76.CrossRef
28.
Zurück zum Zitat Wu M, Wang Y, Yan C, Zhao Y. Study on subclinical hypothyroidism in pregnancy: a bibliometric analysis via citespace. J Matern Fetal Neonatal Med. 2022;35:556–67.CrossRefPubMed Wu M, Wang Y, Yan C, Zhao Y. Study on subclinical hypothyroidism in pregnancy: a bibliometric analysis via citespace. J Matern Fetal Neonatal Med. 2022;35:556–67.CrossRefPubMed
Metadaten
Titel
Tularemia research activity: a bibliometric analysis between 1980 and 2020
verfasst von
Erhan Kaya
Hüseyin Üçer
Publikationsdatum
04.05.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 6/2022
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-022-01837-4

Weitere Artikel der Ausgabe 6/2022

Infection 6/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.